Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders

Hepatitis C is one of the leading causes of death in patients with inherited bleeding disorders. Currently, direct-acting antiviral drugs used for the treatment of hepatitis C have become an effective and a reliable option for people with inherited bleeding disorders. The aim of this study is to rep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Turkish journal of gastroenterology 2022-05, Vol.33 (5), p.414-420
Hauptverfasser:	Sonsuz, Abdullah, Bozcan, Selma, Hatemi, İbrahim, Özdemir, Sebati, Canbakan, Billur, Yıldırım, Süleyman, Gültürk, İlkay, Ar, Cem
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Naphthylamine Adult Anilides - therapeutic use Antiviral agents Antiviral Agents - therapeutic use Blood coagulation factor VIII Blood diseases Carbamates - therapeutic use Child Cyclopropanes Drug therapy Drug Therapy, Combination Genetic aspects Genotype Hemophilia Hepacivirus - genetics Hepatitis C Hepatitis C - drug therapy Hepatitis C virus Hepatitis C, Chronic Humans Lactams, Macrocyclic Liver Cirrhosis Macrocyclic Compounds - therapeutic use Medical research Medicine, Experimental Original LIVER Patient compliance Proline - analogs & derivatives Protease inhibitors Prothrombin complex concentrate Retrospective Studies Ribavirin - therapeutic use Ritonavir - therapeutic use RNA Sulfonamides Uracil - analogs & derivatives Valine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!